TAM
DRNA
Tiverton Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-128,926
| Closed | -$758K | – | 198 |
|
|
2016
Q3 | $758K | Sell |
128,926
-319,032
| -71% | -$1.88M | 0.06% | 143 |
|
|
2016
Q2 | $10M | Buy |
447,958
+219,490
| +96% | +$4.92M | 0.42% | 75 |
|
|
2016
Q1 | $1.23M | Sell |
228,468
-21,532
| -9% | -$115K | 0.04% | 147 |
|
|
2015
Q4 | $2.97M | Sell |
250,000
-50,000
| -17% | -$594K | 0.09% | 127 |
|
|
2015
Q3 | $2.46M | Hold |
300,000
| – | – | 0.05% | 143 |
|
|
2015
Q2 | $4.19M | Hold |
300,000
| – | – | 0.08% | 137 |
|
|
2015
Q1 | $7.21M | Hold |
300,000
| – | – | 0.15% | 115 |
|
|
2014
Q4 | $4.94M | Hold |
300,000
| – | – | 0.1% | 115 |
|
|
2014
Q3 | $3.82M | Buy |
300,000
+260,000
| +650% | +$3.31M | 0.09% | 115 |
|
|
2014
Q2 | $903K | Hold |
40,000
| – | – | 0.02% | 122 |
|
|
2014
Q1 | $1.13M | Buy |
+40,000
| New | +$1.13M | 0.02% | 117 |
|